PACIRA BIOSCIENCES, INC. Operating Leases, Future Minimum Payments, Due in Two Years
PACIRA BIOSCIENCES, INC. (PCRX) had Operating Leases, Future Minimum Payments, Due in Two Years of $7.62 million as of 2018-12-31, per its 10-K filed 2020-02-21.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears · last filed 2020-02-21
- 2018-12-31: Operating Leases, Future Minimum Payments, Due in Two Years $7.62M.
- 2018-09-30: Operating Leases, Future Minimum Payments, Due in Two Years $8.09M.
- 2018-06-30: Operating Leases, Future Minimum Payments, Due in Two Years $8.12M.
- 2018-03-31: Operating Leases, Future Minimum Payments, Due in Two Years $8.12M.
| Period end | Operating Leases, Future Minimum Payments, Due in Two Years |
|---|---|
| 2018-12-31 | $7.62M 10-K · filed 2020-02-21 |
| 2018-09-30 | $8.09M 10-Q · filed 2018-11-01 |
| 2018-06-30 | $8.12M 10-Q · filed 2018-08-02 |
| 2018-03-31 | $8.12M 10-Q · filed 2018-05-03 |
| 2017-12-31 | $8.09M 10-K · filed 2018-02-28 |
| 2017-09-30 | $8.06M 10-Q · filed 2017-11-08 |
| 2017-06-30 | $8.06M 10-Q · filed 2017-08-02 |
| 2017-03-31 | $8.06M 10-Q · filed 2017-05-04 |
| 2016-12-31 | $8.06M 10-K · filed 2017-03-01 |
| 2016-09-30 | $7.88M 10-Q · filed 2016-11-02 |
| 2016-06-30 | $7.88M 10-Q · filed 2016-08-04 |
| 2016-03-31 | $7.88M 10-Q · filed 2016-05-02 |
| 2015-12-31 | $7.88M 10-K · filed 2016-02-25 |
| 2015-09-30 | $7.74M 10-Q · filed 2015-10-27 |
| 2015-06-30 | $7.26M 10-Q · filed 2015-07-30 |
| 2015-03-31 | $7.26M 10-Q · filed 2015-04-30 |
| 2014-12-31 | $7.26M 10-K · filed 2015-02-24 |
| 2014-09-30 | $5.30M 10-Q · filed 2014-10-30 |
| 2014-06-30 | $5.30M 10-Q · filed 2014-07-31 |
| 2014-03-31 | $5.30M 10-Q · filed 2014-05-01 |
| 2013-12-31 | $4.98M 10-K · filed 2014-02-25 |
| 2013-09-30 | $4.76M 10-Q · filed 2013-10-31 |
| 2013-06-30 | $4.76M 10-Q · filed 2013-08-06 |
| 2013-03-31 | $4.59M 10-Q · filed 2013-05-08 |
| 2012-12-31 | $5.28M 10-K · filed 2013-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |